Absolute Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Absolute Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.12M	Buy	26,029 +6,345	+32%	+$858K	1.03%	32
2026 Q1	$2.51M	Buy	19,684 +45	+0.2%	+$5.62K	0.84%	39
2025 Q4	$2.39M	Buy	19,639 +7,339	+60%	+$841K	0.87%	39
2025 Q3	$1.23M	Buy	+12,300	New	+$1.11M	0.53%	60
2022 Q4	–	Sell	-26	Closed	-$2.05K	–	517
2022 Q3	$2.05K	Buy	+26	New	+$2.19K	﹤0.01%	310

Other funds holding XBI

PSP Research Newtown Square, Pennsylvania $188M AUM

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

NHFG

New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

MFS

Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

LRPA

L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Absolute Capital Management's XBI Position: Q2 2026 in Review

Absolute Capital Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 32% in Q2 2026, buying an estimated $858K and bringing the position to 26,029 shares worth $4.12M. The position accounts for 1.03% of the portfolio, ranked #32.

Absolute Capital Management first reported a position in XBI in Q3 2022 and has held it in 5 quarters since. 286 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Absolute Capital Management held 26,029 shares of State Street SPDR S&P Biotech ETF worth $4.12M as of Q2 2026.
Absolute Capital Management bought 6,345 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $858K.
State Street SPDR S&P Biotech ETF made up 1.03% of Absolute Capital Management's portfolio in Q2 2026, its #32 holding.
Absolute Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and has held it in 5 quarters since.
286 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Absolute Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.